Conclusion: NLRC5, LCP2, TMEM229B, and FCRL4 are potential antigens for ESCC mRNA vaccines, and such vaccines may be more suitable for IS2 patients. The gene discussed is FCRL4; the disease is esophageal squamous cell carcinoma.